The FDA is pushing back against claims that its safety restrictions for the abortion pill mifepristone are “onerous and ...

Bi­cy­cle Ther­a­peu­tics shared sev­er­al batch­es of da­ta for its bi­cyclic tox­in con­ju­gate in metasta­t­ic urothe­lial ...

The European Medicines Agency’s human medicines committee (CHMP) handed down 17 recommendations for drug approvals on Friday ...

Boundless Bio is trimming its oncology pipeline in the wake of disappointing cancer data and switching up its leadership just ...

BeiGene acquires MTAP deletion drug SYH2039 from CSPC for $150M, plans combo with BGB-58067, competing with Ideaya's IDE397 ...

San Antonio Breast Cancer Conference featured updates on VEGF bispecifics, oral protein degraders, and data from BeiGene, ...

Repare Therapeutics announced that a combination of two targeted drugs resulted in confirmed responses of 19% and 17% in ...

In an attempt to continue its I&I dominance beyond Humira, Skyrizi and Rinvoq, AbbVie is buying up another small autoimmune ...

The billion-dollar AI-focused startup Xaira Therapeutics deepened its C-suite this week, hiring former Roche executive Paulo ...

Teos Therapeutics halts inupadenant development after poor Phase 2 NSCLC data, and shifts focus to TIGIT program, a combo of ...

Gilead Sciences names Sanofi's Dietmar Berger as new CMO, replacing Merdad Parsey amid challenging year marked by setbacks ...

Editas Medicine will eliminate about 180 roles after failing to find a commercial partner for an experimental sickle cell ...